Filing Details

Accession Number:
0001209191-22-030221
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-18 18:16:54
Reporting Period:
2022-05-16
Accepted Time:
2022-05-18 18:16:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1029142 Dynavax Technologies Corp DVAX Pharmaceutical Preparations (2834) 330728374
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1812025 Justin Burgess C/O Dynavax Technologies
2100 Powell Street, Suite 900
Emeryville CA 94608
Principal Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-16 6,000 $0.00 9,854 No 4 M Direct
Common Stock Disposition 2022-05-17 6,000 $10.00 3,854 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2022-05-16 6,000 $0.00 6,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
Footnotes
  1. Each RSU represents a contingent right to receive one share of common stock. The RSUs vest on the second anniversary of May 15, 2020.